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A
dherent cells perceiveextrinsic signals
by sensing the composite features
(biochemical and/or biophysical) of
the extracellular matrix (ECM). In turn, these
signals govern a plethora of cellular re-
sponses, including migration, proliferation,
differentiation and gene expression.18 Bio-
physical features of the ECM can be on the
nanoscale, and this has driven the develop-
ment of nanoscale biomaterials to help un-
derstand the potential of nanotopography in
modulating cell responses to suit particular
research and therapeutic applications. Over
the past decade, many reports have illu-
strated changes in the behavior of cells to
nanoscale substrates in a wide range of cells,
including human endothelia,9 osteoblasts,10
fibroblasts,11 muscle cells,12 mesenchymal
stem cells,8,1317 and even embryonic stem
cells.1821
For bone regeneration, bone marrow
derived human mesenchymal stromal cells
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ABSTRACT
It is emerging that nanotopographical information can be used to induce osteogenesis from mesenchymal stromal cells from the bone marrow, and it is
hoped that this nanoscale bioactivity can be utilized to engineer next generation implants. However, the osteogenic mechanism of surfaces is currently
poorly understood. In this report, we investigate mechanism and implicate bone morphogenic protein (BMP) in up-regulation of RUNX2 and show that
RUNX2 and its regulatory miRNAs are BMP sensitive. Our data demonstrate that osteogenic nanotopography promotes colocalization of integrins and
BMP2 receptors in order to enhance osteogenic activity and that vitronectin is important in this interface. This provides insight that topographical
regulation of adhesion can have effects on signaling cascades outside of cytoskeletal signaling and that adhesions can have roles in augmenting BMP
signaling.
KEYWORDS: nanotopography . mesenchymal stem cells . metabolomics . osteogenesis . BMP and integrin signaling
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(hMSCs) hold great promise as anautologous cell source
that can differentiate intomature osteoblasts.22,23 These
are the adherent population of the bone marrow
and include osteoprogenitors and multipotent skeletal
stem cells.24,25
A range of studies have focused on nanotopogra-
phical induction of bone formation (osteoinduction).
The rules for topographical guidance of cells, including
hMSCs, are perhaps not as straightforward as for
stiffness, where physiological stiffnesses define hMSC
fate,2628 and substrate chemistry, where tissue spe-
cific chemistries can induce desired phenotypes.29,30
Rules, however, are slowly emerging,31 and there are
a rapidly growing number of studies in this area.
For example, studies have shown hMSC osteogenesis
arising from culture on TiO2 nanotubes. One study
showed that hMSCs osteogenic differentiation was
best achieved with a tube diameter of 100 nm,32 while
another study indicated, using rat-derived MSCs, that
optimal osteogenic differentiation was achieved with
smaller diameters down to 15 nm.33,34 Sub-20 nm
high topographical features35,36 and nanohelices with
collagen-like 67 nm banding16 have also been shown
to be osteogenic.
One of the best described osteogenic nano-
topographies has been fabricated by electron beam
lithography.37 The surface, near-square 50 (NSQ50),
has an offset of up to (50 nm from a perfect square
lattice arrangement of 120 nm diameter, 100 nm
deep pits with 300 nm centercenter spacing and
can specifically promote hMSCs to differentiate into
osteoblasts with similar efficiency to osteogenic
medium.8 This partial disorder, but not total random-
ness, is important because if the offset is zero, the
retention of multipotency results in the maintenance
of a stem cell population, rather than the induction
of differentiation.13 The surface has similarities to the
morphology of collagen X, a nonfibrilar collagen found
during endochondral ossification and nonunion frac-
ture repair that has a nanoscale disordered (but not
random) hexagonal arrangement.38 The surface has
further advantages as the fabrication process means
that exact replicates can be manufactured and,
through use of nickel shims, many replicas injection
molded into plastics with high fidelity. It is facile in that
it has been shown to exert osteogenic effect when
embossed or injection molded into a range of biocom-
patible polymers.3941 These featuresmake the surface
an ideal candidate for further study of nanotopogra-
phical control of osteogenesis.
To date, efforts to understand the process by which
cells interpret nanotopographical cues have been
focused on focal adhesion interactions and the result-
ing changes in intracellular tension. It has been pro-
posed that nanotopography can modulate integrin
clustering and focal adhesion formation, and in turn
regulate stem cell function and differentiation.13,14,4244
Such alterations may result in the modulation of inter-
facial forces to guide cytoskeletal organization and the
organization of transmembrane receptors, and thus
may subsequently regulate the intrinsic signaling of
the cells.45 This may occur through, for example, focal
adhesion kinase (FAK) and G-proteins,42,46 feeding into
major signaling cascades such as themitogen activated
protein kinase-extracellular signal regulated kinase
(MAPK-ERK) 1/2 pathway, and c-jun n-terminal kinase
(JNK) pathway.14,47
However, other key pathways have been less well
studied, if at all, in relation to nanotopography-driven
osteogenesis. Bone morphogenetic proteins (BMPs),
especially BMP2, play a pivotal role in adult skeletal
development and bone formation, and in vivo studies
have demonstrated that BMP receptor signaling is
essential for normal bone formation.48 BMP signals
activate the osteogenic transcription factors RUNX2
(runt-related transcription factor 2) and/or osterix,
mediated by SMAD proteins, to modulate bone matrix
protein expression (canonical BMP signaling).4951
BMPs may also function through p38MAPK and JNK
cascades, (noncanonical BMP signaling) similar to
those characterized for integrin signaling pathways.52
A recent study of human osteoblastic differentiation
showed that the BMP2 signal exerts its function by
cooperation with the integrin Rvβ pairing. The authors
demonstrated that the BMP2 and integrin receptors
could colocalize, and that this synergistic pairing en-
hanced BMP2 signaling and osteogenesis.53
In this study, we examine the temporal expression of
osteogenic genes by hMSCs/progenitors induced by
the NSQ5050 nanotopography and relate findings to
classical Stein and Lian timelines,54 to indicate normal
osteogenic progression on the NSQ5050 nanotopo-
graphy. We update these timelines with information
on transcriptional control, RUNX2 and osterix (OSX),
and investigate very early commitment events. For the
first time, to our knowledge, we show that BMP and
BMPR1a are up-regulated ahead of RUNX2 and that
RUNX2 and its regulatory miRNAs are BMP sensitive,
that the nanofeatures promote colocalization of integ-
rins and BMP2 receptors in order to enhance osteo-
genic activity and that vitronectin is important in this
interface.
RESULTS AND DISCUSSION
Temporal Gene Expression Patterns. For osteogenesis to
occur a sequence of genes needs to be activated in the
correct order to permit proliferation and differentiation.
Three principal development periods (proliferation,
ECMmaturation andmineralization) have been defined
by the sequential expression of the genes associated
with each phase.54 In this progression cell cycle and
growth genes (i.e., c-fos and/or c-myc) are down-
regulated to end proliferation and this is followed by
the process of differentiation, with expression of genes
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encoding ECM proteins that prepare the matrix for
mineralization. Hence, to study growth, transcriptional
control and ECMmaturation for cells culturedonNSQ50
nanotopography, the growth modulator c-myc, the
transcription factors RUNX2 and OSX and the extracel-
lular maturation proteins alkaline phosphatase (ALP),
osteopontin (OPN) and osteocalcin (OCN) were exam-
ined at the transcript level over a 28 day timecourse for
osteoprogenitors cultured on NSQ50 embossed into
polycaprolactone (PCL) (Figure 1A,B) using quantitative
(q-RT) PCR. All data is presented relative to control cells
on planar PCL surfaces (Figure 1B,C).
By day 5, c-myc was down-regulated on NSQ50
compared to cells cultured on the planar control.
Following the repression of growth-related signaling,
transcripts related to osteogenic control were up-
regulated. After 5 days of culture, while c-myc was
becoming repressed, the expression of RUNX2 had
significantly increased on NSQ50. RUNX2 was maxi-
mally expressed at the day 5 time-point, which was
followed by a peak in OSX expression at day 11
compared to baseline expression in cells on control.
Up-regulation of RUNX2 in conjunction with the re-
pression of c-myc expression has been reported
Figure 1. Temporal analysis of osteogenic phenotypical expression on the nanotopography NSQ50 (NSQ, A inset) with all data
relative to MSCs cultured on planar control. (A) Line plot showing expression of proliferative, transcriptional and extracellular
matrix related genes involved in osteogenesis assessed by qPCR. The data shows a slow in proliferation and increase in
transcriptional control (RUNX2 and then OSX) by days 511 the allowing increasing expression of bone matrix related genes
(OCN,OPNandALP) inMSCs onNSQ50 compared to on planar control. (B) Individual histograms showing the data used tomake
the line plot (the plot in A is only made from the data in these histograms, joined points are best fit where data is missing) also
showday28data forOPN,OCNandALP, as expressionwas toohigh touse on the lineplot. (C) Gene expressionofMsx2andDlx 5
byqPCR showingno change relative to control and indicating RUNX2 relatedOSX activation. (D)Westernblot of RUNX2 at 5 says
of culture confirming qPCR data at the protein level (CNTL= planar control). (E) Immunofluorescence of RUNX2 (9 days) andOPN
(28days) showing increased expression onNSQ50 compared to control and confirming qPCR data. For fluorescencemicroscopy
red=actin, blue=nucleus andgreen=RUNX2orOPN. For qPCRdata=mean(SD forn=3 independent experiments (3material
replicated per experiment), *ANOVA p < 0.05. Arrows on graphs show the control level. CNTL = planar control, NSQ = NSQ50.
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elsewhere,55,56 which is sensible as differentiation
occurs in hand with decreased cell growth. RUNX2
plays a central role in the regulation of bone matrix
proteins,57,58 and OSX is a zinc finger transcription
factor that controls downstream pathways in bone
formation that are either dependent on, or indepen-
dent of, RUNX2.59,60 RUNX2-independent initiation of
OSX is mediated by either Msx2 or Dlx5. To examine
the levels of Msx2 and Dlx5 immediately prior to the
OSX peak, we examined expression levels at day 9.
No significant change in expression levels of Msx2 and
Dlx5 were noted compared to cells on planar control
and thus, we propose that the NSQ50 surface induced
OSX expression in a RUNX2-mediated manner
(Figure 1C). It is important that after a brief increase
in RUNX2 expression on NSQ50 that it is subsequently
down-regulated, as prolonged expression can lead
to slower bone growth,61 and even enhance bone
resorption.62
ALP, which is involved in producing free phosphate
for use in mineralization, was then highly expressed at
day 1628, concomitant with increased expression
of OCN, which is a key marker of bony differentiation
involved in the sequestration of calcium formineraliza-
tion. It is interesting that very high levels of OPN were
noted, especially by day 28, in excess of the levels of
OCN (Figure 1B). This is slightly at odds with classical
osteogenic timelines that indicate that both OCN and
OPN should be highly expressed at this time-point.54
However, it is perhaps logical that progenitors
being osteoinduced by material interactions would
use OPN, as it contains the adhesive tripeptide motif
RGD (arginine, glycine, aspartic acid), whereas OCN
does not. Furthermore, MSCs are known to form super-
mature adhesions (adhesions >5 μm long) on the
NSQ50 surface, to support increased intracellular ten-
sion and the endogenous expression of RGD-containing
proteins would facilitate the assembly of large adhe-
sions. RUNX2 and OPN expression was confirmed at
the protein level usingWestern blotting (Figure 1D) and
immunofluorescence (Figure 1E).
Temporal Metabolite Signaling. Employment of untar-
geted metabolomics at very early time points (days 3, 5
and 7) was used to try and direct subsequent experi-
ments on mechanism (i.e., use of an untargeted ap-
proach to provide targets) and provided some
interesting trends.Metabolites linked toMAPK signaling
were down-regulated with time suggesting a reduction
in proliferative signaling63 and reflecting the c-myc
mRNA data (Figure 2). However, metabolites that have
been linked to calcium signaling tended to be up-
regulated, particularly at day 5 (Figure 2). This is inter-
esting as calcium signaling has been linked to BMP2
signaling64 and this provides rational for study of BMP2
as an early stage event in materials induced osteogen-
esis. Other notable metabolites were likely involved
in amino acid metabolism (up and down-regulations),
growth (down-regulated) and energy (becomes down-
regulated) (Figure 2). While only a small number of
metabolites were identified that were involved at all
time points, the analysis highlights interactions with
proliferation and differentiation control tying in well
with results discussed in Figure 1. Kyoto Encyclopedia
of Genes and Genomes (KEGG) analysis revealed
changes in fatty acid biosynthesis pathways suggesting
alterations in energy demand in MSCs on NSQ50
compared to control (Supporting Information, Figures
S1S3). It is noted that changes were quite small, but
it is likely that the cells were in a lag phase in this early
stage of culture on the nanotopography.
BMP2 Switches on RUNX2. It would be expected that a
reduction in cell proliferation and activation of RUNX2
would be controlled by extrinsic factors to initiate
osteogenesis. Thus, with help of the above data from
temporal metabolomic analysis (Figure 2), we investi-
gated the role of bonemorphogenic protein 2 (BMP2)65
in the activation of RUNX2 on the NSQ50 nanotopo-
graphy. QPCR comparison of cells on NSQ50 compared
to planar control at days 111 showed that by day 3 the
BMP2 receptor, BMPR1a, was significantly up-regulated
and by day 5, BMP2 itself and RUNX2 were also up-
regulated (Figure 3A). This suggests that the cells were
primed for BMP signaling ahead of RUNX2 activation.
Of course, cell culture media contains many proteins
including, e.g., transforming growth factor (TGF)β (BMP
belongs to the TGF superfamily).66 Hence, we used low
serum media (containing 1% serum; the MSCs were
dead within 48 h with 0% serum) to see if RUNX2
expression still occurred. Immunofluorescence indi-
cated localization of RUNX2 within the nucleus even
in low serum, and this indicates that the cells were
producing endogenous BMP2 in response to the
NSQ50 surface (Figure 3A inset).
We reaffirmed up-regulation of BMP2 and its re-
ceptor, BMPR1a at the transcript level showing they
were significantly up-regulated at day 3 in cells on
NSQ50 compared to control (Figure 3B) and then used
qPCR to demonstrate that the downstream intracellular
signaling molecules SMAD1 and SMAD5 were highly
expressed relative to controls at day 5 (Figure 3C). The
engagement of BMP2 with its receptor, BMPR1a, phos-
phorylates SMADmessengers, and the phosphorylated
SMADs then translocate into the nucleus and are
recruited by RUNX2 to initiate transcription from BMP-
responsive genes.49
To investigate the relation of the BMP2 signal to
the induction of transcription from the RUNX2 gene,
progenitors cultured on the NSQ50 topography and
planar control were treated with the BMP2 antagonist
noggin for 5 days. RUNX2 expression was measured by
qPCR andWestern blotting to determine the transcript
and protein-level responses. If the BMP signal was
blocked, RUNX2 was inhibited back to control levels,
indicating that RUNX2 expressionwas BMP-dependent
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(Figure 3D; densitometry of the bandprovides arbitrary
values of 35.5 for NSQ and 27.9 for NSQ with noggin).
Furthermore, if progenitors were cultured for up to
28 days on NSQ50 with noggin, OPN production was
reduced back to control levels (Figure 3E), indicating
that the osteogenesis was regulated by BMP2 via
RUNX2.
We note that the activation of BMPs can also trigger
SMAD-independent signaling pathways, including ERK,
mitogen-activated protein kinase p38 (p38MAPK) and
JNK, which have previously been implicated in materi-
als-driven osteogenesis through integrin dependent
pathways.14,47,52 For these pathways to be activated
by BMP2 in a SMAD-independent manner, interaction
of bone morphogenetic protein receptor associated
molecule 1 (BRAM1) or X-linked inhibitor of apoptosis
protein (XIAP), and downstream TGFβ activated kinase
1 (TAK1) and activation of its binding protein (TAB1)
activation have to be initiated.66 There was no statisti-
cally significant difference observed in Tab1 gene ex-
pression between cells on NSQ50 substrates and
on the planar control (Figure 3F). This suggests that
NSQ50-initiated osteogenesis is not reliant on SMAD-
independent BMP signaling.
BMP2 Receptor Colocalizes with Integrins. To further in-
vestigate the mechanisms of NSQ50 osteogenic differ-
entiation, we examined the expression of integrin
subunits R3, R4, Rv, β1, β3 and β5. Significant up-
regulation of integrin subunits R4, Rv and β5 relative
to planar controls were noted at day 5 (Figure 4A).
Integrins are the receptors that primarily link adherent
cells to the ECM and these receptors play an indis-
pensible role in cell adhesion, migration, proliferation
and differentiation in many cell types.67 Integrin bind-
ing with ECM components depends upon the pairing
of R and β units, and it is widely accepted that the
pairing of Rv with β1/β3/β5 and R5 with β1 binds to
the RGD motif in OPN, and fibronectin (mainly Rvβ3)
and vitronectin (primarily Rvβ5 but also can use Rvβ3)
in ECM.67 As integrin β5 had been highlighted by our
analysis, suggesting a key role for vitronectin in adhe-
sion to the nanopatterned surface, we blocked this
subunit using an antagonistic antibody, and observed
the effect on RUNX2 expression. However, the data
Figure 2. Temporal metabolite analysis for metabolites extracted fromMSCs cultured on NSQ50 compared toMSCs cultured
on planar control. Eleven metabolites were identified at all time-points (days 3, 5 and 7) with roles in proliferation (MAPK),
growth, amino acid metabolism, Ca2þ signaling and energy (functions identified via the Ingenuity Pathway database). The
trends forMAPK-relatedmetaboliteswas that of down-regulationwith time (trend-line arrows: red andblack linear), the trend
for Ca2þsignaling-related metabolites was general up-regulation (vertical arrows). Graph shows mean of n = 3 material
replicates at each time point. Note that L-tyrosine and L-aspartic acid were identified by use of standards and the others were
annotated by mass and retention time (see Materials and Methods).
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Figure 3. BMP2 analysis of nanotopography stimulated osteogenic phenotypical expression. (A) Temporal profile of BMP2
and its receptor BMPR1a compared to RUNX2 for MSCs cultured on NSQ50 compared to control showing that BMP and
BMPR1a are up-regulated ahead of RUNX2 and are maintained through RUNX2 expression (inset RUNX2 localization within
the nuclei of MSCs cultured on NSQ50 in low serum media). (B) Gene up-regulation of BMP2 and its receptor BMPR1a were
assessed by qPCR and the up-regulation of BMP2 was confirmed using Western blotting after MSCs were cultured on the
NSQ50 surface for 3 days compared to on planar controls. (C) The abundance of BMP signal intracellular signaling molecules
SMAD1 and SMAD5 was also increased at 3 days cell culture on NSQ50 compared to planar control. (D) The inhibition of the
BMP2 signal by noggin resulted in a return to control levels of the osetogenic transcription factor RUNX2 at both gene and
protein level after MSCs were cultured on NSQ50 for 5 days compared to on planar control. (E) With longer culture (28 days)
MSCs on the NSQ surface did not express osteopontin. (F) Gene expression of Tab1 by qPCR in MSCs cultured on NSQ50
surface showed no difference to on planar control. This data shows that RUNX2 and subsequent osteoblast phenotype
development on NSQ50 is BMP and SMAD dependent. For fluorescence microscopy red = actin, blue = nucleus and green =
OPN. For qPCR data =mean( SD for n = 3 independent experiments (3material replicates per experiment), *ANOVA p< 0.05.
Arrows on graphs show the control level. CNTL = planar control, NSQ = NSQ50, NOG = noggin, STD = standard culturemedia.
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suggested that integrin β5 was not directly linked with
the up-regulation of RUNX2, since the abundance of
RUNX2 transcripts on NSQ50 were not significantly
different with or without β5 blocked (Figure 4B). How-
ever, looking at β3 expression when β5 was blocked
showed that this other subunit that cells can also
exploit to bind to vitronectin becomes up-regulated
suggesting cellular redundancy and that the cells
could still exploit vitronectin even with β5 unavailable
(Figure 4C) despite β3 not being up-regulated by
standard culture of MSCs on NSQ50 (Figure 4A). To
test the role of vitronectin further, we culturedMSCs on
NSQ50 coated with vitronectin (uncoated NSQ50 acting
as control) and stained for RUNX2 after 5 days of culture.
While all cellswere RUNX2positive,with RUNX2 localized
to the cell nuclei on the standardNSQ50 surfaces, RUNX2
expression was notably more intense when cultured on
NSQ50 precoated with vitronectin (Figure 4D).
To study the vitronectin receptor further, we con-
sidered recent studies that showed integrins could
exert their effects on cells through crosstalk with
other ECM components, such as TGFs,68,69 including
BMP2.53 Therefore, we proposed that there was a
functional relation between these two signals. Double
immunostaining using specific β5 and BMPR1 anti-
bodies demonstrated the colocalization of these two
receptors in hMSCs on the NSQ50 surface (Figure 5A).
However, on the planar surface, while β5 could be seen
as part of the adhesion, no colocalization was noted
(Figure 5A). This observation was confirmed in the
whole cell population by coimmunoprecipitation
(Figure 5B; we note that only very small protein yields
were obtained after lysis and pull-down form the
material surfaces). Furthermore, when the BMP2 signal
was blocked using noggin, up-regulation of integrins
RV,β4 andβ5 (as identified in Figure 4)were abrogated
back to planar control levels, accompanying the down-
regulation of the osteoblastic phenotype (Figure 5C).
This suggests that BMP2 might help mediate integrin-
related signaling in response to the osteogenic nano-
topography. It could be postulated that this may help
with the formation of supermature adhesions (adhesions
>5 μm in length) that have been shown to be necessary
to support the high levels of intracellular tension
required by the cells during the osteogenesis of
hMSCs.14,47,7072 It could be further speculated that
use of vitronectin receptors is important in osteo-
genesis as the cells need to form the super mature
Figure 4. Integrin expression in response to NSQ50 nanotopography. (A) Integrins Rv, R4 and β5 were up-regulated at the
gene level after 5 days culture on NSQ50, and it is notable the Rvβ5makeup the vitronectin receptor. (B) However, inhibition
ofβ5with antibodies (β5Ab= standard culture,þβ5Ab= inhibition) did not alter expressionof theosteogenic transcription
factor RUNX2. (C) Concomitantly with inhibition of β5, the other possible vitronectin β subunit, β3, became up-regulated. (D)
Immunofuorescent staining of RUNX2 in MSCs cultured on NSQ50 or NSQ50 precoated with vitronectin (VN) showing
increasedRUNX2expressionwith coated surfaces (blue=DAPI, green=RUNX2). Together, the results illustrate a likely role for
the vitronectin receptor in topographically driven osteogenesis. For qPCR data = mean ( SD for n = 3 independent
experiments (3 material replicated per experiment), *ANOVA p < 0.05. Arrows on graphs show the control level.
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adhesions and use of vitronectin allows the cells to
bridge from one set of integrins to the next as a part of
a single, larger, adhesion than, e.g., fibronectin.73
The potential role of vitronectin was further inves-
tigated by repeating the duel Itgβ5/BMPR1a staining
but on NSQ50 precoated with vitronectin. Figure 5D
shows increased colocalization of the receptors in
MSCs cultured on vitronectin coated NSQ50 compared
to standard NSQ50 surfaces. This indicates that vitro-
nectin helps mediate the nanotopographically induced
receptor colocalization.
BMP2 and Nontranscriptional Regulation. MicroRNAs are
classified as noncoding regulatory RNAs acting in di-
verse biological processes, predominantly bymediating
the translational repression of their target mRNA spe-
cies. Recent studies have shownmiRNAs play important
roles in the regulation of skeletal differentiation7476
and are involved in osteospecific differentiation via
targeting of RUNX2.77 To gain further insight into the
molecular mechanisms underlying BMP2-induced
osteogenic differentiation of hMSCs, we focused on
miRNAs targeting RUNX2 and OSX. A search for miRNAs
that were predicted to target RUNX2 and OSX was
performed using the targetscan database and the
extent of sequence conservation was examined using
University of California Santa Cruz genome browser.
The search results showed miR-23a and -23b are
highly conserved and complementary to RUNX2 30UTR
Figure 5. Integrins colocalize with the BMP2 receptor when cultured on NSQ50. (A) Double immunostaining after 5 days cell
culture of MSCs on the NSQ50 surface and planar control using integrin β5 (red) and BMPRIa (green) specific antibodies. Only
MSCs cultured on NSQ50 demonstrated colocalization (yellow and arrows in the outset merge). On planar control, while
integrin expression in adhesions was seen (outset Itgβ5), colocalization to BMPR1a was not. (B) The colocalization of integrin
β5 and BMPRIa was confirmed by coimmunoprecipitation using Rvβ5 (arrows) and BMPRIa (arrowheads) specific antibodies.
(C) Gene expression of integrinswas assessed by qPCR after the BMP signal was inhibited by noggin. Integrins (Rv, β4, and β5)
were down-regulated compared to MSCs without noggin treatment. (D) Colocalization (yellow) of Itgβ5 (red) and BMPR1a
(green) was increased for NSQ50 precoated with vitronectin (VN) compared to uncoated NSQ50 surfaces with dense receptor
copositioning seen (outset). For qPCR data = mean ( SD for n = 3 independent experiments (3 material replicated per
experiment), *ANOVA p < 0.05, **p < 0.01. Arrow on graph shows the control level. For immunofluorescence, blue = DNA.
NSQ = NSQ50, NOG = noggin.
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(untranslated region), andmiR-96 and -143 to the 30UTR
of OSX (Supporting Information, Figure S4).
Using qPCR, miR-23a and -23b were measured at
day 5, and miR-96 and -143 at day 11 of culture on
NSQ50 vs planar control, as RUNX2 and OSX were
highly induced by the NSQ50 topography at day 5
and day 11 respectively. miR-23b was down-regulated
in cells cultured on the nanotopography under normal
culture conditions as compared with the planar
control, while the abundance of miR-23a remained
unchanged (Figure 6A). This indicates that miR-23b
contributes to the activation of RUNX2 in hMSCs
on NSQ50. In addition, when cells were exposed to
noggin, the expression of miR-23b returned to the
basal levels observed in cells cultured on the planar
contol (Figure 6C). This suggests that miR-23b target-
ing for RUNX2was regulated by the BMP2 signal in cells
on NSQ50. However, miR-96 andmiR-143, which target
the 30UTR of OSX, were up-regulated in cells on the
topography compared to the controls (Figure 6B)
while overexpression of OSX was observed. Addition
of noggin had no effect (Figure 6D) This suggests that
the expression of miR-96 and -143 were independent
of BMP2 signals. The activated expression of miR-96
and -143 correlated with the activated expression
of OSX, suggesting that miR-96 and -143 most likely
had a positive regulatory role on OSX that was BMP-
independent (perhaps through having a negative
effect on OSX regulatory mRNAs). Together with the
observations that the expression levels of Msx2 and
Dlx5 were unchanged prior to the maximal increase
in RUNX2 expression, this suggests that on the NSQ50
surface, BMP2-induced expression of RUNX2 is suffi-
cient for OSX expression, and thus OSX expression is
indirectly rather than directly linked to BMP signaling.
SUMMARY
There have been a number of reports of the roles of
integrins and cytoskeletal tension on the osteospecific
differentiation of hMCS. In this study, our osteoinduc-
tive NSQ50 topography was utilized to investigate
the role of BMP2 in initiating osteogenic signaling in
concert with cues from the integrins. We illustrate a
role for BMP2 in the induction of RUNX2 through the
repression of miR-23b. Subsequently, this induction of
RUNX2 expression induced the transcription of OSX.
These transcription factors then permitted the normal
progression toward osteoblastic differentiation in line
with classical guides.
It is notable that in hMSCs onNSQ50, higher levels of
the BMP receptor BMPR1a were observed at the tran-
script and protein level compared to planar controls,
Figure 6. MicroRNA (miR) targeting of osteogenic transcription factors RUNX2 and OSX. (A) The expression of MiR-23a and -
23b was assessed by qPCR after 5 days of MSC culture on NSQ50 at which time RUNX2 expression was maximal compared to
on planar control. The data shows the expression of MiR-23a was unchanged and MiR-23b was down-regulated on NSQ50
suggesting negative regulation of RUNX2 by MiR-23b. (B) The expression of miRs-96 and -143 were measured after 9 days of
MSC culture onNSQ50, at which timeOSX expressionwasmaximal compared to planar control. The data shows bothmiRs-96
and -143 were up-regulated suggesting possitive regulation of OSX. (C) Expression of MiR-23a and -23b was assessed for
MSCs cultured on NSQ50 and treated with the BMP signal inhibitor noggin compared to cells in standard culture. The data
shows up-regulation of MiR-23b indicating MiR-23b is BMP2 dependent. (D) Expression of miRs-96 and -143 was uneffected
by noggin suggesting BMP2 independance. All MiR qPCR datawere normalized to the endogenous control small nuclear RNA
U6. For qPCR data =mean( SD for n = 3 independent experiments (3 material replicated per experiment), *ANOVA p < 0.05.
Arrows on graphs show the control level. NOG = noggin, STD = standard culture media.
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apparently aiding the clustering of the integrin β5
subunits that are used by hMSCs to adhere to
vitronectin.
It is further noteworthy that very high levels of OPN,
above levels of OCN, were expressed by the hMSCs
on NSQ50. This may be related to the dual role of OPN
as a protein containing the pro-adhesive tripeptide
motif -RGD, as well as a calcium sequestering com-
ponent of the ECM.
The temopral study indicates that hMSCs on planar
control do not catch up with the osteospecific differ-
entiation observed in cells on NSQ50 as levels of BMP,
BMPR1a, RUNX2, OSX and ALP do not increase above
NSQ50 levels as hMSCs on NSQ50 stop expressing
these markers. Thus, we show that cells on NSQ50
produce more osteoblasts rather than simply pro-
ducing osteoblasts first (note that osteoblasts on the
NSQ50 surface do go onto form mineral, Supporting
Information, Figure S5).
This report further illustrates the potential for nano-
scale materials in dissecting stem cell mechanisms
without recourse to the use of soluble factors to drive
differentiation. It also illustrates that osteogenesis
on the NSQ50 material is a highly regulated process
that appears to start with increased BMP2 sensitivity
and then enter a well-orchestrated cascade of growth,
transcriptional and extracellular matrix-modulating
events.
MATERIALS AND METHODS
NSQ50 Nanotopography. A “near square” arrangement of nano-
pits with 120 nm diameter, 100 nm depth and with an average
300 nm center-to-center spacing with up to(50 nm offset were
fabricated by electron beam lithography8 and replicated into
1  1 cm2 polycaprolactone (PCL) (cut from sheets of the
polymer ε-polycaprolactone) by embossing on a hot plate at
70 C as has been previously described.78
Vitronectin (VN) Immobilization. NSQ50 surfaceswere incubated
with basal medium containing 5 μg/mL of vitronectin at 4 C for
24 h. The surface (NSQ50þNV) was washed with 1PBS and
prewarmed at 37 C before MSCs were seeded on.
MSC Isolation and Culture. hMSCs were isolated from human
bone marrow obtained from patients undergoing routine ar-
throplasty, with local ethical approval. Bone marrow aspirates
were diluted 1:2 with basal medium (DMEM plus 10% FBS,
1% sodium pyruvate, 1% nonessential amino acids and 2%
penicillin). Following cell separation on a Ficoll gradient, mono-
nucleated cells were collected at the interphase and seeded
into 75 cm3 flask. After 3 days, fresh medium was added.
Medium was changed every 3 days, and cells were subcultured
at a 1:3 split using trypsin versine. Cells of passage 1 or 2 were
used for experimental work. For seeding on to the biomaterial
substrates cells were seeded with density of 1  104 cells/cm2.
Cells were cultured in basal culture medium for the different
time points used.
Cell Starvation. Cells were cultured in low serum medium,
which contains DMEM, 1% FBS, 1% sodium pyruvate, 1% non
essential amino acids and 2% penicillin, for 3 days, and then the
low serummediumwas replaced by fresh basal medium for the
rest of the culture period.
BMP2 Antagonist Treatment. Human noggin protein (Sigma,
UK) was dissolved in double processed tissue culture H2O to a
final concentration of 5 ng/μL. Cells were seeded on PCL sheets
in basal medium, and after allowing cells to settle down on the
substrates, 10 μL noggin solution was added on to produce a
final concentration 50 ng/mL. Cells were cultured in the pre-
sence of noggin for 5 days, then themedium was replaced with
fresh medium without noggin (denoted as “blocked” in this
report) for the rest of the culture period.
Quantitative Real-Time PCR (qRT-PCR). Cells were harvested, and
total RNA was extracted using the RNeasy Micro kit (Invitrogen,
UK). The total RNA was then reverse transcribed to cDNA
using Superscript II reverse transcription kit (Invitrogen, UK).
For microRNA, reverse transcription was performed using
the Thermotranscript kit (Invitrogen, UK). The qRT-PCR was
performed using a real time 7500 PCR machine (Applied
Biosystems, UK) using the relative standard curve method.
GAPDH served as endogenous control for protein encoding
genes, and small nuclear RNA U6 for microRNA.
qRT-PCR Data Analysis. All data were normalized to endo-
genous control genes and planar control samples, and given
as mean ( SD from three independent experiments. Statistical
analysis was carried out using two-tailed ANOVAs for paired
samples, and the threshold for statistical significance was set at
a value of p < 0.05.
Immunofluorescence Staining. Cells were washed with 1PBS
and fixed with 10% formaldehyde solution at 37 C for 15 min.
Cellswere thenpermeablised using a buffer (10.3g ofNaCl, 0.06 g
of MgCl26H2O, 0.476 g of HEPES in 100mL of PBS, adjusted to pH
7.2 before adding 0.5 mL of Triton X) at 4 C for 5 min. Cells were
blocked for nonspecific binding using 1% BSA and incubating
at 37 C for 5 min. After blocking, the primary antibodies
(Anti-RUNX2, cat. 051478, Millipore UK; Anti-OPN, sc-21742,
Santa cruz biotechnology; Anti-BMPRIa, cat. 315-BR, R&D system;
Anti-integrin β5, cat. 4708, Cell signaling technology) against the
proteins of interest along with phalloidin-rhodamine (Invitrogen,
UK) were added and incubated at 37 C for 1 h. Cells were next
washed with 0.5% Tween in PBS (PBST) three times (5 min each).
Then a biotinylated secondary antibody (Vector laboratories, UK)
was added and incubated at 37 C for 1 h followed by 3  5%
PBST washing. Streptavidin-FITC (Vector Laboratories, UK) was
added and incubated at 4 C for 30 min followed by a 3  5%
PBSTwash. For nuclear visualization, a small drop of vectroshield-
DAPI (Vector Laboratories, UK) was added before placing on the
coverslip prior to fluorescence microscopy.
Immunoprecipitation. Proteins were isolated using lysis
buffer and then centrifuged at 13 000 rpm for 15 min at 4 C.
The supernatant was transferred to a fresh tube with protein A
agarose beads (Cat. 9863, Cell signaling technology) to preclean
the samples. After 1 h of incubation at 4 C, samples were
centrifuged and collected into new tubes. Protein A agarose
beads were incubated with primary antibodies (Human Integrin
Rvβ5 antibody, cat. MAB2528, R&D systems) at 4 C for 1 h and
centrifuged at 4 C for 2min and the supernatant discarded. The
mixture of primary antibody and agarose beads were washed
with lysis buffer and then centrifuged, this was repeated three
times. Equal amount of protein samples were added into
mixture of primary antibody and agarose beads and incubated
under rotation at 4 C overnight. Samples were subsequently
washed four times with lysis buffer and then proteins were
eluted with SDS buffer for Western blot analysis.
Western Blot. Total protein was extracted from cells using
RIPA lysis buffer. The lysate was collected and clarified by
centrifugation at 13000 rpm for 5 min and supernatant trans-
ferred into a new tube. Protein was quantified using Quick Start
Bradford protein assay Kit (Cat. 5000203, BIO_RAD, UK). Total
protein with concentration of 10ug/mL for each sample along
with protein molecular weight marker heated at 95 C for 5 min
and then were loaded on 12-well 412% Bis-Tris-HCl polyacry-
lamide gels and run in 1NuPAGE MOPS SDS running buffer
at 200 V for 50 min. Proteins separated on the SDS-PAGE gel
were transferred on to Hybond-Nþ membrane (Amersham
Bioscience, UK). The membrane was dried and then dipped in
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methanol for 30 s, and then blocked in blocking buffer (1 g of
nonfat dry milk in 20mL of PBST) overnight at 4 C. The blocked
membrane was washed three times (10 min for each) with PBST
buffer and then the membrane was incubated with primary
antibody (Anti-RUNX2, cat. 051478, Millipore UK; Human
BMP2 antibody, cat. MAB3551, R&D systems; Human Integrin
Rvβ5 antibody, cat. MAB2528, R&D systems; Anti-BMPRIa, cat.
315-BR, R&D system; Anti-GAPDH, cat. ABS16, Millipore, UK)
against the proteins (diluted 1:1000 in blocking buffer) at room
temperature for 2 h followed by three washes (each for 10 min)
with PBST buffer. The membrane was then incubated with
secondary antibody (antimouse IgG-HRP, sc-2031; antirabbit
IgG-HRP, sc-2030; antigoat IgG-HRP, sc-2020; Santa cruz
technology) linked to a horseradish peroxidase (dilution
1:10 000 or 1:15 000 in blocking buffer) reporter enzyme at
room temperature for 1 h followed by three washes (each for
10 min) with PBST buffer. The dried membrane was then
immersed in colorimetric immunodetection reagents (Amersham
Bioscience, UK) for 30 s and then dried on a soft tissue for X-ray
viewing.
Metabolomics. Metabolite extraction from cells cultured on
topographies and control samples for 1 week was done using
ice cold chloroform:methanol:water (1:3:1,v/v) on a shaker for
1 h maintained at 4 C. Samples were centrifuged, and 10 μL of
the supernatant injected on to the LCMS system.
The LC separation was carried out using hydrophilic inter-
action chromatography with a ZIC-pHILIC 150 mm  4.6 mm,
5 μm column (Merck Sequant), operated by an UltiMate liquid
chromatography system (Dionex, Camberley, Surrey). The LC
mobile phase was run with 20 mM ammonium carbonate in
water (A) and acetonitrile (B). The mobile phase was run at a
linear gradient for 15 min from 2080% A, maintained at 5% A
for 5min and then re-equilibrated to 20%A.Mass spectrometric
detection was performed using an Orbitrap Exactive (Thermo
Fisher Scientific, Hemel Hempstead, U.K.) within themass range
m/z 701400 in polarity switching mode.
Chromatographic peak selection andmetabolite identification
weredone using XCMS/Ideom/MzMatch analysis pipeline79,80 and
measured peak intensities by LCMS were normalized against
protein content as measured using the Bradford assay as detailed
previously.81 Metabolite identification were matched against a set
of known standards within accurate mass (<3 ppm) and chroma-
tographic retention time (<5%) windows. Compounds lacking
metabolite standards were annotated using accurate mass and
predicted retention time as described by Creek et al.82 All known
metabolites associated with Kegg accession identifiers (KEGG ID#)
were submitted to the KEGG database (http://www.genome.jp/
kegg/tool/map_pathway1.html), and potentially relevant path-
ways were noted.
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